Suchergebnisse - "Sarilumab"

PubPharm (143)

11

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19 : a systematic review and meta-analysis

enthalten in: Emerging microbes & infections | 2022

von Yu, S. | Koh, D. | Choi, M. | +4

12

Correspondence on : 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al

enthalten in: Annals of the rheumatic diseases | 2022

von Cheng, C. | Zhang, F.

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

13

Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to : 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang

enthalten in: Annals of the rheumatic diseases | 2022

von Della-Torre, E. | Landoni, G. | Zangrillo, A. | +1

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

14

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

enthalten in: Joint bone spine | 2022

von Marotte, H. | Fakra, E. | Flipo, R. | +4

15

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

16

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

17

Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis

enthalten in: Expert opinion on drug discovery | 2022

von Maioli, G. | Caporali, R. | Favalli, E.

18

Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis : analysis of two Phase 3 randomised clinical trials

enthalten in: Modern rheumatology | 2022

von Tanaka, Y. | Takahashi, T. | Sumi, M. | +5

19

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Burmester, G. | Bykerk, V. | Buch, M. | +6

20

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients : A systematic review and meta-analysis

enthalten in: Reviews in medical virology | 2022

von Peng, J. | Fu, M. | Mei, H. | +5